发明名称 |
Therapeutic composition with enhanced endothelium targeting |
摘要 |
A composition that includes nanoparticles with binding affinity for platelets, and methods for using this composition to treat vascular disease are disclosed. |
申请公布号 |
US9072665(B2) |
申请公布日期 |
2015.07.07 |
申请号 |
US201313737842 |
申请日期 |
2013.01.09 |
申请人 |
Abbott Cardiovascular Systems Inc. |
发明人 |
Ludwig Florian N.;Hossainy Syed F. A.;Pacetti Stephen D. |
分类号 |
A61K9/127;A61K9/51;A61K9/00;A61K47/48;B82Y5/00 |
主分类号 |
A61K9/127 |
代理机构 |
Squire Patton Boggs (US) LLP |
代理人 |
Squire Patton Boggs (US) LLP |
主权项 |
1. A composition comprising:
a plurality of nanoparticles each comprising a first functional group and a second functional group, wherein:
the first functional group and the second functional group are operatively coupled to a surface of the nanoparticles;the first functional group has binding affinity for platelets, and comprises one or more first peptides or first proteins or any combination thereof;the second functional group has binding affinity for endothelium, and comprises one or more second peptides or second proteins, or any combination thereof; and a bioactive agent encapsulated within, adhered to a surface of or integrated into the structure of the nanoparticles, wherein the bioactive agent does not promote clotting or thrombogenesis. |
地址 |
Santa Clara CA US |